Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Olatec Therapeutics set to launch dapansutrile Phase 2 trial in Parkinson’s disease Olatec Therapeutics, Inc. (Olatec), a leader in the field of selective NLRP3 inhibitors, has embarked on a journey… byPallavi MadhirajuFebruary 20, 2024